Peter Carmeliet

This inventor holds 21 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 12 EPO patents. Top assignees: Life Sciences Research Partners Vzw, Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw, Vib Vzw. Active years: 2005-2018.

USPTO Granted Patents = 21 (Patent Applications = 12)

% Patents Active = 23.8

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 66(Granted Patents)

Location History:

Oud-Heverlee, BE (2005 - 2006)
Zwijnaarde, BE (2010)
Landen, BE (2007 - 2011)
Bladen, BE (2015)
Blanden, BE (2007 - 2018)

Company Filing History:

14 out of 41

Life Sciences Research Partners Vzw

patents

11 out of 44

Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw

D. Collen Research Foundation Vzw

patents

5. 3 out of 7

Flanders Interuniversity Institute for Biotechnology

Collen Research Foundation Vzw

patent

8. 1 out of 84

K.u. Leuven Research & Development

patents

9. 1 out of 1

Life Science Research Partners Vzw

patent

10. 1 out of 529

Ludwig Institute for Cancer Research Limited

Viaams Interuniversitair Instituut Voor Biotechnologie Vzw

patent

14. 1 out of 190

Vrije Universiteit Brussel

patents

where one patent can have more than one assignee

Years Active: 2005-2018

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10106601 - Inhibition of PLGF to treat philadelphia chromosome positive leukemia (2018-10-23),

2. 9234025 - Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor (2016-01-12),

3. 9085617 - Anti-angiogenic therapy (2015-07-21),

4. 8758748 - Anti-angiogenic therapy (2014-06-24),

5. 8741862 - PHD2 inhibition for blood vessel normalization, and uses thereof (2014-06-03),

6. 8003096 - Means and methods for the recruitment and identification of stem cells (2011-08-23),

7. 7888322 - Use of VEGF and homologues to treat neuron disorders (2011-02-15),

8. 7875704 - Anti-PLGF antibody (2011-01-25),

9. 7867490 - Treatment of liver cirrhosis and its complications (2011-01-11),

10. 7863246 - Treatment of amyotrophic lateral sclerosis (2011-01-04),

11. 7858593 - Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degeneration (2010-12-28),

12. 7727971 - Use of placental growth factor for treating ischemic muscle disease (2010-06-01),

13. 7709450 - Stimulation of vascularization with VEGF-B-186 (2010-05-04),

14. 7687463 - Treatment of amyotrophic lateral sclerosis (2010-03-30),

15. 7592314 - Use of VEGF and homologues to treat neuron disorders (2009-09-22),

Title: Peter Carmeliet - The Innovative Mind from Blanden, BE

Introduction: Peter Carmeliet is a renowned inventor hailing from Blanden, Belgium, known for his groundbreaking contributions to the field of science and technology.

Latest Patents: Peter Carmeliet holds several patents in the areas of biotechnology, pharmaceuticals, and medical devices, showcasing his continuous dedication to innovation.

Career Highlights: Throughout his illustrious career, Peter Carmeliet has worked tirelessly to push the boundaries of scientific research, with a focus on developing novel solutions to complex problems in the medical and biotechnological fields.

Collaborations: Peter Carmeliet has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange in the scientific community.

Conclusion: Peter Carmeliet's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the realm of science and technology.